Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 274

1.

First Detection of Chlamydia trachomatis 'Swedish' Variant (nvCT) in a Russian Couple with Infertility.

Feodorova V, Sultanakhmedov E, Saltykov Y, Zaitsev S, Utz S, Corbel M, Gaydos C, Quinn T, Motin V.

Open Microbiol J. 2018 Oct 18;12:343-352. doi: 10.2174/1874285801812010343. eCollection 2018.

2.

Measurement of absolute K X-ray emission intensities in the decay of 103mRh.

Riffaud J, Cassette P, Lacour D, Lourenço V, Tartès I, Kellett MA, Corbel M, Lépy MC, Domergue C, Destouches C, Carcreff H, Vigneau O.

Appl Radiat Isot. 2018 Apr;134:399-405. doi: 10.1016/j.apradiso.2017.10.003. Epub 2017 Oct 4. Review.

PMID:
29031491
3.

Quality, immunogenicity and stability of meningococcal serogroup ACWY-CRM197, DT and TT glycoconjugate vaccines.

Beresford NJ, Martino A, Feavers IM, Corbel MJ, Bai X, Borrow R, Bolgiano B.

Vaccine. 2017 Jun 16;35(28):3598-3606. doi: 10.1016/j.vaccine.2017.03.066. Epub 2017 Apr 10.

4.

Russian vaccines against especially dangerous bacterial pathogens.

Feodorova VA, Sayapina LV, Corbel MJ, Motin VL.

Emerg Microbes Infect. 2014 Dec;3(12):e86. doi: 10.1038/emi.2014.82. Epub 2014 Dec 17. Review.

5.

Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.

Ochiai M, Horiuchi Y, Yuen CT, Asokanathan C, Yamamoto A, Okada K, Kataoka M, Markey K, Corbel M, Xing D.

Hum Vaccin Immunother. 2014;10(7):2074-80. doi: 10.4161/hv.28952.

6.

Relationship of immunogenicity to protective potency in acellular pertussis vaccines.

Xing D, Asokanathan C, Xu YH, Bolgiano B, Douglas-Bardsley A, Zhang S, Wang J, Corbel M.

Hum Vaccin Immunother. 2014;10(7):2066-73. doi: 10.4161/hv.28765.

7.

An international collaborative study of the effect of active pertussis toxin on the modified Kendrick test for acellular pertussis vaccines.

Xing D, Gaines Das R, Douglas-Bardsley A, Asokanathan C, Corbel M.

Biologicals. 2014 Mar;42(2):101-8. doi: 10.1016/j.biologicals.2013.11.008. Epub 2013 Dec 31.

PMID:
24388289
8.
9.

Report of an International collaborative study to establish the first WHO reference reagents for BCG vaccines of three different sub-strains.

Ho MM, Markey K, Rigsby P, Hockley J, Corbel MJ.

Vaccine. 2011 Jan 10;29(3):512-8. doi: 10.1016/j.vaccine.2010.10.066. Epub 2010 Nov 4.

PMID:
21055496
10.

Report of an international collaborative study to evaluate the suitability of multiplex PCR as an identity assay for different sub-strains of BCG vaccine.

Markey K, Ho MM, Choudhury B, Seki M, Ju L, Castello-Branco LR, Gairola S, Zhao A, Shibayama K, Andre M, Corbel MJ.

Vaccine. 2010 Oct 8;28(43):6964-9. doi: 10.1016/j.vaccine.2010.08.045. Epub 2010 Aug 21.

PMID:
20732463
11.

Evaluation of fourth international standard for whole cell pertussis vaccine.

Das RG, Newland P, Asokanathan C, Douglas-Bardsley A, Corbel M, Xing D.

Biologicals. 2010 Nov;38(6):644-51. doi: 10.1016/j.biologicals.2010.07.006. Epub 2010 Aug 14.

PMID:
20709568
12.

An in vitro assay system as a potential replacement for the histamine sensitisation test for acellular pertussis based combination vaccines.

Yuen CT, Horiuchi Y, Asokanathan C, Cook S, Douglas-Bardsley A, Ochiai M, Corbel M, Xing D.

Vaccine. 2010 May 7;28(21):3714-21. doi: 10.1016/j.vaccine.2010.03.009. Epub 2010 Mar 20.

PMID:
20307594
13.

Prospects for new plague vaccines.

Feodorova VA, Corbel MJ.

Expert Rev Vaccines. 2009 Dec;8(12):1721-38. doi: 10.1586/erv.09.129. Review. Erratum in: Expert Rev Vaccines. 2010 Jan;9(1):110.

PMID:
19943765
14.

Vaccines and biosimilarity: a solution or a problem?

Corbel MJ, Cortes Castillo Mde L.

Expert Rev Vaccines. 2009 Oct;8(10):1439-49. doi: 10.1586/erv.09.97. Review.

PMID:
19803764
15.

Modified intra-cerebral challenge assay for acellular pertussis vaccines: comparisons among whole cell and acellular vaccines.

Gaines-Das R, Horiuchi Y, Zhang SM, Newland P, Kim Y, Corbel M, Xing D.

Vaccine. 2009 Nov 16;27(49):6824-32. doi: 10.1016/j.vaccine.2009.09.014. Epub 2009 Sep 16.

PMID:
19765397
16.

Characterization of reference materials for human antiserum to pertussis antigens by an international collaborative study.

Xing D, Wirsing von König CH, Newland P, Riffelmann M, Meade BD, Corbel M, Gaines-Das R.

Clin Vaccine Immunol. 2009 Mar;16(3):303-11. doi: 10.1128/CVI.00372-08. Epub 2008 Dec 24.

17.

Current progress with Moraxella catarrhalis antigens as vaccine candidates.

Mawas F, Ho MM, Corbel MJ.

Expert Rev Vaccines. 2009 Jan;8(1):77-90. doi: 10.1586/14760584.8.1.77. Review.

PMID:
19093775
18.

Transferability of dermal temperature histamine sensitization test for estimation of pertussis toxin activity in vaccines.

Gaines-Das R, Ochiai M, Douglas-Bardsley A, Asokanathan C, Horiuchi Y, Rigsby P, Corbel MJ, Xing DK.

Hum Vaccin. 2009 Mar;5(3):166-71. Epub 2009 Mar 15.

PMID:
18758243
19.

Report of an international collaborative study to establish the suitability of using modified ATP assay for viable count of BCG vaccine.

Ho MM, Markey K, Rigsby P, Jensen SE, Gairola S, Seki M, Castello-Branco LR, López-Vidal Y, Knezevic I, Corbel MJ.

Vaccine. 2008 Aug 26;26(36):4754-7. doi: 10.1016/j.vaccine.2008.06.026. Epub 2008 Jun 27.

PMID:
18586063
20.

WHO Working Group on revision of the Manual of Laboratory Methods for Testing DTP Vaccines-Report of two meetings held on 20-21 July 2006 and 28-30 March 2007, Geneva, Switzerland.

Corbel MJ, Das RG, Lei D, Xing DK, Horiuchi Y, Dobbelaer R; WHO Working Group.

Vaccine. 2008 Apr 7;26(16):1913-21. doi: 10.1016/j.vaccine.2008.02.013. Epub 2008 Feb 21.

PMID:
18336960
21.

Perspectives for the treatment of brucellosis in the 21st century: the Ioannina recommendations.

Ariza J, Bosilkovski M, Cascio A, Colmenero JD, Corbel MJ, Falagas ME, Memish ZA, Roushan MR, Rubinstein E, Sipsas NV, Solera J, Young EJ, Pappas G; International Society of Chemotherapy; Institute of Continuing Medical Education of Ioannina.

PLoS Med. 2007 Dec;4(12):e317. No abstract available.

22.

A retrospective study on the quality of Haemophilus influenzae type b vaccines used in the UK between 1996 and 2004.

Bolgiano B, Mawas F, Burkin K, Crane DT, Saydam M, Rigsby P, Corbel MJ.

Hum Vaccin. 2007 Sep-Oct;3(5):176-82. Epub 2007 Apr 27.

PMID:
17786035
23.

Characterization of human embryonic stem cell lines by the International Stem Cell Initiative.

International Stem Cell Initiative, Adewumi O, Aflatoonian B, Ahrlund-Richter L, Amit M, Andrews PW, Beighton G, Bello PA, Benvenisty N, Berry LS, Bevan S, Blum B, Brooking J, Chen KG, Choo AB, Churchill GA, Corbel M, Damjanov I, Draper JS, Dvorak P, Emanuelsson K, Fleck RA, Ford A, Gertow K, Gertsenstein M, Gokhale PJ, Hamilton RS, Hampl A, Healy LE, Hovatta O, Hyllner J, Imreh MP, Itskovitz-Eldor J, Jackson J, Johnson JL, Jones M, Kee K, King BL, Knowles BB, Lako M, Lebrin F, Mallon BS, Manning D, Mayshar Y, McKay RD, Michalska AE, Mikkola M, Mileikovsky M, Minger SL, Moore HD, Mummery CL, Nagy A, Nakatsuji N, O'Brien CM, Oh SK, Olsson C, Otonkoski T, Park KY, Passier R, Patel H, Patel M, Pedersen R, Pera MF, Piekarczyk MS, Pera RA, Reubinoff BE, Robins AJ, Rossant J, Rugg-Gunn P, Schulz TC, Semb H, Sherrer ES, Siemen H, Stacey GN, Stojkovic M, Suemori H, Szatkiewicz J, Turetsky T, Tuuri T, van den Brink S, Vintersten K, Vuoristo S, Ward D, Weaver TA, Young LA, Zhang W.

Nat Biotechnol. 2007 Jul;25(7):803-16. Epub 2007 Jun 17.

PMID:
17572666
24.

Physico-chemical characterisation and immunogenicity of a multi-valent candidate vaccine against non-typeable Haemophilus influenzae and Moraxella catarrhalis.

Mawas F, Ho MM, Huskisson R, Saydam M, Corbel MJ.

Vaccine. 2007 Jun 15;25(25):4801-8. Epub 2007 Apr 25.

PMID:
17507119
25.

WHO working group on standardisation and control of acellular pertussis vaccines--report of a meeting held on 16-17 March 2006, St. Albans, United Kingdom.

Xing DK, Corbel MJ, Dobbelaer R, Knezevic I.

Vaccine. 2007 Apr 12;25(15):2749-57. Epub 2006 Sep 29.

PMID:
17368348
26.

Evaluation of the saccharide content and stability of the first WHO International Standard for Haemophilus influenzae b capsular polysaccharide.

Mawas F, Bolgiano B, Rigsby P, Crane D, Belgrave D, Corbel MJ.

Biologicals. 2007 Oct;35(4):235-45. Epub 2007 Mar 6.

PMID:
17337205
27.

ADP-ribosylation activity in pertussis vaccines and its relationship to the in vivo histamine-sensitisation test.

Gomez SR, Yuen CT, Asokanathan C, Douglas-Bardsley A, Corbel MJ, Coote JG, Parton R, Xing DK.

Vaccine. 2007 Apr 30;25(17):3311-8. Epub 2007 Jan 19.

PMID:
17287049
28.

Preclinical laboratory evaluation of a bivalent Staphylococcus aureus saccharide-exotoxin A protein conjugate vaccine.

Ho MM, Bolgiano B, Martino A, Kairo SK, Corbel MJ.

Hum Vaccin. 2006 May-Jun;2(3):89-98. Epub 2006 May 23.

PMID:
17012902
29.
30.

Investigation in a model system of the effects of combinations of anthrax and pertussis vaccines administered to service personnel in the 1991 Gulf War.

Rijpkema SG, Adams T, Rigsby P, Xing DK, Corbel MJ.

Hum Vaccin. 2005 Jul-Aug;1(4):165-9. Epub 2005 Jul 1.

PMID:
17012879
31.
32.

Effect of different forms of adenylate cyclase toxin of Bordetella pertussis on protection afforded by an acellular pertussis vaccine in a murine model.

Cheung GY, Xing D, Prior S, Corbel MJ, Parton R, Coote JG.

Infect Immun. 2006 Dec;74(12):6797-805. Epub 2006 Sep 18.

33.

Development of a carbohydrate binding assay for the B-oligomer of pertussis toxin and toxoid.

Gomez SR, Xing DK, Corbel MJ, Coote J, Parton R, Yuen CT.

Anal Biochem. 2006 Sep 15;356(2):244-53. Epub 2006 Jun 5.

PMID:
16782039
34.

WHO discussion on the improvement of the quality control of BCG vaccines. Pasteur Institute, Paris, France, 7 June 2005.

Knezevic I, Corbel MJ.

Vaccine. 2006 May 1;24(18):3874-7. No abstract available.

PMID:
16755681
35.

Evaluation of adenyl cyclase toxin constructs from Bordetella pertussis as candidate vaccine components in an in vitro model of complement-dependent intraphagocytic killing.

Prior S, Fleck RA, Gillett ML, Rigsby PR, Corbel MJ, Stacey GN, Xing DK.

Vaccine. 2006 May 29;24(22):4794-803. Epub 2006 Apr 3.

PMID:
16675078
36.

Immune interaction between components of acellular pertussis-diphtheria-tetanus (DTaP) vaccine and Haemophilus influenzae b (Hib) conjugate vaccine in a rat model.

Mawas F, Dickinson R, Douglas-Bardsley A, Xing DK, Sesardic D, Corbel MJ.

Vaccine. 2006 Apr 24;24(17):3505-12. Epub 2006 Feb 23.

PMID:
16524648
37.

A review of WHO International Standards for botulinum antitoxins.

Jones RG, Corbel MJ, Sesardic D.

Biologicals. 2006 Sep;34(3):223-6. Epub 2006 Feb 20. Review.

PMID:
16490362
38.
40.

Control and lot release of meningococcal group C conjugate vaccines.

Suker J, Feavers IM, Corbel MJ, Jones C, Bolgiano B.

Expert Rev Vaccines. 2004 Oct;3(5):533-40. Review.

PMID:
15485333
41.

Adjuvanticity of native and detoxified adenylate cyclase toxin of Bordetella pertussis towards co-administered antigens.

Macdonald-Fyall J, Xing D, Corbel M, Baillie S, Parton R, Coote J.

Vaccine. 2004 Oct 22;22(31-32):4270-81.

PMID:
15474718
42.

Characterisation of adsorbed anthrax vaccine by two-dimensional gel electrophoresis.

Whiting GC, Rijpkema S, Adams T, Corbel MJ.

Vaccine. 2004 Oct 22;22(31-32):4245-51.

PMID:
15474715
43.

Report on a WHO consultation on the characterisation of BCG strains, Imperial College, London 15-16 December 2003.

Corbel MJ, Fruth U, Griffiths E, Knezevic I.

Vaccine. 2004 Jul 29;22(21-22):2675-80. No abstract available.

PMID:
15309814
44.

A nitric oxide-releasing salbutamol elicits potent relaxant and anti-inflammatory activities.

Lagente V, Naline E, Guenon I, Corbel M, Boichot E, Burgaud JL, Del Soldato P, Advenier C.

J Pharmacol Exp Ther. 2004 Jul;310(1):367-75. Epub 2004 Apr 14.

PMID:
15084649
45.

Determination of serum antibody to Bordetella pertussis adenylate cyclase toxin in vaccinated and unvaccinated children and in children and adults with pertussis.

Cherry JD, Xing DX, Newland P, Patel K, Heininger U, Corbel MJ.

Clin Infect Dis. 2004 Feb 15;38(4):502-7. Epub 2004 Jan 29.

PMID:
14765342
46.

Toxicity and potency evaluation of pertussis vaccines.

Corbel MJ, Xing DK.

Expert Rev Vaccines. 2004 Feb;3(1):89-101. Review.

PMID:
14761246
47.

WHO Working Group on the standardisation and control of pertussis vaccines-report of a meeting held on 6-7 May 2003, Ferney Voltaire, France.

Corbel MJ, Kreeftenberg JG, Knezevic I.

Vaccine. 2004 Jan 2;22(3-4):293-300. No abstract available.

PMID:
14670307
48.

Enhancement of gelatinase activity during development of subepithelial fibrosis in a murine model of asthma.

Corbel M, Caulet-Maugendre S, Germain N, Lagente V, Boichot E.

Clin Exp Allergy. 2003 May;33(5):696-704.

PMID:
12752601
49.

Novel configurations of high molecular weight species of the pertussis toxin vaccine component.

Fowler S, Byron O, Jumel K, Xing D, Corbel MJ, Bolgiano B.

Vaccine. 2003 Jun 2;21(19-20):2678-88.

PMID:
12744905
50.

Modifications of the catalytic and binding subunits of pertussis toxin by formaldehyde: effects on toxicity and immunogenicity.

Fowler S, Xing DK, Bolgiano B, Yuen CT, Corbel MJ.

Vaccine. 2003 Jun 2;21(19-20):2329-37.

PMID:
12744863

Supplemental Content

Loading ...
Support Center